AlzeCure Pharma to Present at Aktiespararna in Stockholm on 14 October

STOCKHOLM, SE / ACCESS Newswire / October 8, 2026 / AlzeCure Pharma AB (publ) (STO:ALZCUR)(FRA:AC6), which develops small-molecule drug candidates for CNS diseases with a focus on Alzheimer's disease and pain, today announced that the company will …